Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status

被引:55
作者
Maron, Barry J. [1 ]
Maron, Martin S. [2 ]
Lesser, John R. [1 ]
Hauser, Robert G. [1 ]
Haas, Tammy S. [1 ]
Harrigan, Caitlin J. [3 ]
Appelbaum, Evan [3 ]
Main, Michael L. [4 ]
Roberts, William C. [5 ]
机构
[1] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA
[2] Tufts Univ New England Med Ctr, Div Cardiol, Hypertroph Cardiomyopathy Ctr, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Med, Div Cardiovasc,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[4] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA
[5] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA
关键词
D O I
10.1016/j.amjcard.2007.09.101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two patients with hypertrophic cardiomyopathy are reported from the recent experience of the Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, demonstrating limitations in the risk stratification algorithm currently used for this disease. One patient, an asymptomatic 21-year-old male college student, was prophylactically implanted with a cardioverter-defibrillator. This decision was based largely on the presence of apparent extensive myocardial fibrosis identified by contrast-enhanced cardiovascular magnetic resonance imaging, currently not considered a risk factor in this disease. Fifteen months later, ventricular fibrillation was interrupted by an appropriate defibrillator shock. The other patient, an asymptomatic 15-year-old male subject without any apparent high-risk markers, died suddenly at home. Necropsy examination of the heart identified scarring confined to portions of both left ventricular papillary muscles, possibly representing a substrate for ventricular tachyarrhythmias. In conclusion, these 2 cases demonstrate that present strategies for assessing high-risk status in hypertrophic cardiomyopathy are inadequate to identify all such patients. However, while the anecdotal nature of these observations cannot yet justify altering the general guidelines for implantation of defibrillators for the primary prevention of sudden death related to hypertrophic cardiomyopathy, 1 of our 2 cases suggests a future role for contrast-enhanced cardiovascular magnetic resonance in the risk stratification of this complex disease. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:544 / 547
页数:4
相关论文
共 19 条
[1]   Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia [J].
Basso, C ;
Thiene, G ;
Corrado, D ;
Buja, G ;
Melacini, P ;
Nava, A .
HUMAN PATHOLOGY, 2000, 31 (08) :988-998
[2]   SCARRING OF THE LEFT-VENTRICULAR PAPILLARY-MUSCLES IN SICKLE-CELL DISEASE [J].
BEREZOWSKI, K ;
MAUTNER, GC ;
ROBERTS, WC .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (15) :1368-1370
[3]   Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients [J].
Elliott, PM ;
Poloniecki, J ;
Dickie, S ;
Sharma, S ;
Monserrat, L ;
Varnava, A ;
Mahon, NG ;
McKenna, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2212-2218
[4]  
Harrigan C.J., 2007, J CARDIOVASC MAGN R, V9, P428
[5]   Long-term follow-up of implantable cardioverter, defibrillator therapy for hypertrophic cardiomyopathy [J].
Jayatilleke, I ;
Doolan, A ;
Ingles, J ;
McGuire, M ;
Booth, V ;
Richmond, DR ;
Semsarian, C .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (09) :1192-1194
[6]   Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy - In vivo imaging of the pathologic substrate for premature cardiac death? [J].
Kim, RJ ;
Judd, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) :1568-1572
[7]   PAPILLARY MUSCLE FIBROSIS IN PRIMARY MYOCARDIAL DISEASE [J].
MARCUS, FI ;
GOMEZ, L ;
GLANCY, DL ;
EWY, GA ;
ROBERTS, WC .
AMERICAN HEART JOURNAL, 1969, 77 (05) :681-&
[8]   Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy [J].
Maron, Barry J. ;
Spirito, Paolo ;
Shen, Win-Kuang ;
Haas, Tammy S. ;
Formisano, Francesco ;
Link, Mark S. ;
Epstein, Andrew E. ;
Almquist, Adrian K. ;
Daubert, James P. ;
Lawrenz, Thorsten ;
Boriani, Giuseppe ;
Estes, N. A. Mark, III ;
Favale, Stefano ;
Piccininno, Marco ;
Winters, Stephen L. ;
Santini, Massimo ;
Betocchi, Sandro ;
Arribas, Fernando ;
Sherrid, Mark V. ;
Buja, Gianfranco ;
Semsarian, Christopher ;
Bruzzi, Paolo .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (04) :405-412
[9]   Hypertrophic cardiomyopathy - A systematic review [J].
Maron, BJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10) :1308-1320
[10]   Clinical course of hypertrophic cardiomyopathy with survival to advanced age [J].
Maron, BJ ;
Casey, SA ;
Hauser, RG ;
Aeppli, DM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) :882-888